The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Glycoxidation and Diabetic Complications: Modern Lessons and a Warning?
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The amounts of AGEs in exogenous sources are usually much higher than those of endogenously produced AGEs2–4,24.”
From Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury (2021) · cites this paper as [24]
In the citing paper
“Thus, it is likely that the intake of foods and/or beverages with high levels of exogenous AGEs create more health problems than endogenously produced AGEs, although both exogenous and endogenous AGEs are similar in their biological functions and potentially act synergistically to stimulate oxidative stress, inflammation, and cellular damage, contributing to detrimental pathophysiology2–4,24.”
From Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury (2021) · cites this paper as [24]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
A Clinical Trial of the Effects of Dietary Patterns on Blood Pressure
Appel, L. J., Moore, T. J., Obarzanek, E., Vollmer, W. M., Svetkey, L. P., Sacks, F. M., Bray, G. A., Vogt, T. M., Cutler, J. A., Windhauser, M. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361601 · Cited by 5,981
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
Celermajer, D. S., Sorensen, K. E., Gooch, V. M., Spiegelhalter, D. J., Miller, O. I., Sullivan, I. D., Lloyd, J. K., & Deanfield, J. E. (1992) · The Lancet · doi:10.1016/0140-6736(92)93147-f · Cited by 4,742
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,023
Self-citationKrauss, R. M., Eckel, R. H., Howard, B., Appel, L. J., Daniels, S. R., Deckelbaum, R. J., Erdman, J. W., Kris-Etherton, P., Goldberg, I. J., Kotchen, T. A., et al. (2000) · Circulation · doi:10.1161/01.cir.102.18.2284 · Cited by 1,458
Wolff, S. P., & Dean, R. T. (1987) · Biochemical Journal · doi:10.1042/bj2450243 · Cited by 1,272
Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose
Thornalley, P. J., LANGBORG, A., & Minhas, H. S. (1999) · Biochemical Journal · doi:10.1042/bj3440109 · Cited by 1,209
Fu, M.-X., Requena, J. R., Jenkins, A. J., Lyons, T. J., Baynes, J. W., & Thorpe, S. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.9982 · Cited by 822
Activation of Receptor for Advanced Glycation End Products
Schmidt, A. M., Yan, S. D., Wautier, J., & Stern, D. M. (1999) · Circulation Research · doi:10.1161/01.res.84.5.489 · Cited by 799
Koschinsky, T., He, C.-J., Mitsuhashi, T., Bucala, R., Liu, C., Buenting, C., Heitmann, K., & Vlassara, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6474 · Cited by 792
Self-citationAdvanced glycoxidation end products in commonly consumed foods
Goldberg, T., Cai, W., Peppa, M., Dardaine, V., Baliga, B. S., Uribarri, J., & Vlassara, H. (2004) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2004.05.214 · Cited by 744
Self-citationImproved Arterial Compliance by a Novel Advanced Glycation End-Product Crosslink Breaker
Kass, D. A., Shapiro, E. P., Kawaguchi, M., Capriotti, A. R., Scuteri, A., deGroof, R. C., & Lakatta, E. G. (2001) · Circulation · doi:10.1161/hc3801.097806 · Cited by 735
Vlassara, H., Cai, W., Crandall, J., Goldberg, T., Oberstein, R., Dardaine, V., Peppa, M., & Rayfield, E. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242407999 · Cited by 668
Self-citationLipid advanced glycosylation: pathway for lipid oxidation in vivo.
Bucala, R., Makita, Z., Koschinsky, T., Cerami, A., & Vlassara, H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6434 · Cited by 571
Self-citationMiyata, T., de Strihou, C. V. Y., Kurokawa, K., & Baynes, J. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00302.x · Cited by 521
Wei, M., Gaskill, S. P., Haffner, S., & Stern, M. (1998) · Diabetes Care · doi:10.2337/diacare.21.7.1167 · Cited by 515
Shinohara, M., Thornalley, P. J., Giardino, I., Beisswenger, P. J., Thorpe, S. R., Onorato, J., & Brownlee, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119885 · Cited by 513
Nutritional and toxicological aspects of the Maillard browning reaction in foods
O'Brien, J., Morrissey, P. A., & Ames, J. M. (1989) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398909527499 · Cited by 477
Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice
Yamamoto, Y., Kato, I., Doi, T., Yonekura, H., Ohashi, S., Takeuchi, M., Watanabe, T., Yamagishi, S.-I., Sakurai, S., Takasawa, S., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11771 · Cited by 475
Vlassara, H., Li, Y. M., Imani, F., Wojciechowicz, D., Yang, Z., Liu, F.-T., & Cerami, A. (1995) · Molecular Medicine · doi:10.1007/bf03401604 · Cited by 421
Self-citationLi, Y. M., Mitsuhashi, T., Wojciechowicz, D. C., Shimizu, N., Li, J., Stitt, A. W., He, C., Banerjee, D., & Vlassara, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11047 · Cited by 338
Self-citationUribarri, J., Peppa, Μ., Cai, W., Goldberg, T., Lu, M. M., He, C., & Vlassara, H. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000051593.41395.b9 · Cited by 331
Self-citationAdvanced Glycation End Products and Endothelial Dysfunction in Type 2 Diabetes
Tan, K. C. B., Chow, W.-S., Ai, V. H. G., Metz, C. N., Bucala, R., & Lam, K. S. L. (2002) · Diabetes Care · doi:10.2337/diacare.25.6.1055 · Cited by 318
The AGE‐receptor in the pathogenesis of diabetic complications
Vlassara, H. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.233 · Cited by 304
Self-citationHofmann, S. M., Dong, H. H., Li, Z., Cai, W., Altomonte, J., Thung, S. N., Zeng, F., Fisher, E. A. A., & Vlassara, H. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2082 · Cited by 296
Self-citationRole of the Maillard Reaction in Diabetes Mellitus and Diseases of Aging
Thorpe, S. R., & Baynes, J. (1996) · Drugs & Aging · doi:10.2165/00002512-199609020-00001 · Cited by 285
Freedman, B. I., Wuerth, J.-P., Cartwright, K. J., Bain, R. P., Dippe, S. E., Hershon, K. S., Mooradian, A. D., & Spinowitz, B. (1999) · Controlled Clinical Trials · doi:10.1016/s0197-2456(99)00024-0 · Cited by 257
Gugliucci, A., & Bendayan, M. (1996) · Diabetologia · doi:10.1007/bf00403957 · Cited by 247
Cai, W., Gao, Q.-D., Zhu, L., Peppa, Μ., He, C., & Vlassara, H. (2002) · Molecular Medicine · doi:10.1007/bf03402014 · Cited by 236
Self-citationNonenzymatic glucosylation and glucose-dependent cross-linking of protein.
Eble, A. S., Thorpe, S. R., & Baynes, J. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44682-5 · Cited by 214
Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products
Zheng, F., He, C., Cai, W., Hattori, M., Steffes, M. W., & Vlassara, H. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.283 · Cited by 207
Self-citationUribarri, J., Peppa, Μ., Cai, W., Goldberg, T., Lu, M. M., Baliga, S. K., Vassalotti, J. A., & Vlassara, H. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00779-0 · Cited by 197
Self-citationHe, C., Sabol, J., Mitsuhashi, T., & Vlassara, H. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1308 · Cited by 191
Cai, W., He, J. C., Zhu, L., Peppa, M., Lu, C., Uribarri, J., & Vlassara, H. (2004) · Circulation · doi:10.1161/01.cir.0000135587.92455.0d · Cited by 177
Self-citationDietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice
Lin, R.-Y., Choudhury, R. P., Cai, W., Lu, M. M., Fallon, J. T., Fisher, E. A. A., & Vlassara, H. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00050-9 · Cited by 169
Self-citationLi, Y. M., Tan, A. X., & Vlassara, H. (1995) · Nature Medicine · doi:10.1038/nm1095-1057 · Cited by 153
Self-citationAdverse effects of dietary glycotoxins on wound healing in genetically diabetic mice
Peppa, M., Brem, H., Ehrlich, P., Zhang, J.-G., Cai, W., Li, Z., Croitoru, A., Thung, S., & Vlassara, H. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2805 · Cited by 153
Bucala, R., Mitchell, R., Arnold, K. S., Innerarity, T. L., Vlassara, H., & Cerami, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10828 · Cited by 130
Self-citationFetal or Neonatal Low-Glycotoxin Environment Prevents Autoimmune Diabetes in NOD Mice
Peppa, Μ., He, C., Hattori, M., McEvoy, R. C., Zheng, F., & Vlassara, H. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1441 · Cited by 129
Self-citationStitt, A. W., He, C., Friedman, S. G., Scher, L. A., Rossi, P., Ong, L., Founds, H., Li, Y. M., Bucala, R., & Vlassara, H. (1997) · Molecular Medicine · doi:10.1007/bf03401819 · Cited by 126
Self-citationOxidized fat in the diet, postprandial lipaemia and cardiovascular disease
Cohn, J. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200202000-00004 · Cited by 125
Glycoxidation and inflammation in renal failure patients
Peppa, Μ., Uribarri, J., Cai, W., Lu, M. M., & Vlassara, H. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.11.022 · Cited by 117
Self-citationLin, R.-Y., Reis, E. D., Dore, A. T., Lu, M., Ghodsi, N., Fallon, J. T., Fisher, E. A., & Vlassara, H. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00008-4 · Cited by 109
Self-citationHe, C., Koschinsky, T., Bünting, C. E., & Vlassara, H. (2001) · Molecular Medicine · doi:10.1007/bf03401949 · Cited by 93
Self-citationSakata, N., Imanaga, Y., Meng, J., Tachikawa, Y., Takebayashi, S., Nagai, R., Horiuchi, S., Itabe, H., & Takano, T. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00149-x · Cited by 82
Therapeutic potential of AGE inhibitors and breakers of AGE protein cross-links
Foiles, P. G., Founds, H. W., & Vasan, S. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.11.1977 · Cited by 75
Zheng, F., Cai, W., Mitsuhashi, T., Vlassara, H., & Bucala, R. (2001) · Molecular Medicine · doi:10.1007/bf03401963 · Cited by 70
Self-citationGoals for nutrition in the year 2000
Willett, W. C. (1999) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.49.6.331 · Cited by 66
Effects of a diet rich in advanced glycation end products in the rat remnant kidney model
Šebeková, K., Faist, V., Hofmann, T. F., Schinzel, R., & Heidland, A. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50084 · Cited by 51
Carbonyl Stress and Diabetic Complications
Miyata, T., Ishikawa, N., & de Strihou, C. V. Y. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.178 · Cited by 49
Vargemezis, V., & Thodis, E. D. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.suppl_6.106 · Cited by 40
Physiological and safety aspects of Maillard browning of foods.
Tae-hyun, L. E. E., Kimiagar, M., Pintauro, S. J., & Chichester, C. O. (1981) · PubMed · Cited by 40
Advanced Glycoxidation: A New Risk Factor for Cardiovascular Disease?
Peppa, Μ., Uribarri, J., & Vlassara, H. (2002) · Cardiovascular Toxicology · doi:10.1385/ct:2:4:275 · Cited by 38
Self-citationThe roles of insulin resistance, hyperinsulinemia, and thiazolidinediones in cardiovascular disease
Uwaifo, G. I., & Ratner, R. E. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.08.009 · Cited by 33
A Food Chemist'S View of Advanced Glycation End-Products
Henle, T. (2001) · Peritoneal Dialysis International · doi:10.1177/089686080102103s38 · Cited by 11
Research works printed but not linked: 5
- Uribarri J, Cai W, Peppa M, Goldberg T, Vlassara H. Renal clearance of advanced glycoxidation end products (AGE) is markedly reduced in diabetic patients in the absence of impaired GFR. J Am Soc Nephrol 2003;14:394A. · DOI
- Lu CY, He CJ, Cai WJ, Vlassara H. Overexpression of AGE-R1 inhibits AGE-induced MAPK and NF-kB activations in murine mesangial cells. Diabetes 2003;52(Suppl 1):A50(abstract).
- Cai W, He C, Zhu L, Peppa M, Lu C, Vlassara H. Dietary-AGE-modified LDL is a potent redox-sensitive MAPk stimulant in diabetic patients. Circulation (in press).
- Stirban A, Sander D, Buenting CE, Ruetter R, Ziegler D, Vlassara H, Koschinsky T. Food advanced glycation endproducts (AGE) acutely impair endothelial function in patients with diabetes mellitus (DM). Diabetes 2003;52(Suppl 1):A19 (abstract).
- American Cancer Society/World Health Organization Food. Nutrition and the prevention of cancer: A global perspective. Washington, DC: National Academy Press, 1997.
Cited by
Sorted by citations
Advanced glycation end products in foods and a practical guide to their reduction in the diet
Uribarri, J., Woodruff, S., Goodman, S., Cai, W., Chen, X., Pyzik, R., Yong, A., Striker, G. E., & Vlassara, H. (2010) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2010.03.018 · Cited by 1,289
Self-citationAdvanced glycation endproducts in food and their effects on health
Poulsen, M. W., Hedegaard, R. V., Andersen, J. M., de Courten, B., Bügel, S., Nielsen, J., Skibsted, L. H., & Dragsted, L. O. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.06.052 · Cited by 751
Rungratanawanich, W., Qu, Y., Wang, X., Essa, M. M., & Song, B.-J. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00561-7 · Cited by 411
Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms
Stirban, A. O., Gawlowski, T., & Roden, M. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.11.006 · Cited by 375
Diabetes and Advanced Glycoxidation End Products
Huebschmann, A. G., Regensteiner, J. G., Vlassara, H., & Reusch, J. E. B. (2006) · Diabetes Care · doi:10.2337/dc05-2096 · Cited by 336
Self-citation
Metadata
- Authors
- Vlassara, H., & Uribarri, J.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Vlassara, Helen
- ORCID
- Uribarri, Jaime
- Venue
- Reviews in Endocrine and Metabolic Disorders
- Published
- 2004-08
- Volume
- 5
- Issue
- 3
- Pages
- 181-188
- ISSN
- 1389-9155 (ISSN-L)
- 1573-2606
- OpenAlex
- W2072265321
- Cited by
- 105
- References
- 59
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 8 · 2023: 10 · 2022: 2 · 2021: 6 · 2020: 6 · 2019: 2 · 2018: 5 · 2017: 5 · 2016: 4 · 2015: 3 · 2014: 2 · 2013: 8 · 2012: 3
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Reviews in Endocrine and Metabolic Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Aldose Reductase and Taurine
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- glycoxidation, advanced glycation end products, diabetes complications, diabetes mellitus, oxidative stress
- MeSH terms
- Animals, Diabetes Mellitus, Glycolysis, Humans, Hyperglycemia, Glycation End Products, Advanced, Mice, Knockout, Oxidative Stress, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
